[1]
“Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series”, Mediterr J Hematol Infect Dis, vol. 9, no. 1, p. e2017004, Jan. 2017, doi: 10.4084/mjhid.2017.004.